Benzinga - Tue, 20 Apr 2021 12:01:33 -0400
Benzinga - Tue, 20 Apr 2021 09:18:50 -0400
Benzinga - Tue, 20 Apr 2021 08:18:37 -0400
Benzinga - Tue, 20 Apr 2021 08:04:11 -0400
Benzinga - Tue, 20 Apr 2021 07:51:37 -0400
Benzinga - Tue, 20 Apr 2021 06:44:03 -0400
Benzinga - Thu, 11 Mar 2021 07:31:11 -0400
Benzinga - Thu, 18 Feb 2021 09:40:49 -0400
Benzinga - Sun, 14 Feb 2021 09:10:14 -0400
Benzinga - Thu, 11 Feb 2021 08:18:41 -0400
Benzinga - Wed, 10 Feb 2021 13:03:05 -0400
Benzinga - Wed, 10 Feb 2021 09:01:44 -0400
Benzinga - Wed, 10 Feb 2021 08:34:42 -0400
Benzinga - Wed, 10 Feb 2021 07:15:02 -0400
Benzinga - Wed, 10 Feb 2021 06:54:16 -0400
load more
Sector: Health Care.Industry: Biotechnology
KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates through the region of United States.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-30
REV
Q3 2021Est.ActualSurprise
EPS-0.560
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KALVKalVista Pharmaceuticals1.78%613.1M

KalVista Pharmaceuticals Company Questions & Answers

Q

How do I buy KalVista Pharmaceuticals (KALV) stock?

A

You can purchase shares of KalVista Pharmaceuticals (NASDAQ: KALV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are KalVista Pharmaceuticals's (KALV) main competitors?

A

Other companies in KalVista Pharmaceuticals’s space includes: Orchard Therapeutics (NASDAQ:ORTX), CytomX Therapeutics (NASDAQ:CTMX) and Eagle Pharmaceuticals (NASDAQ:EGRX).

Q

What is the target price for KalVista Pharmaceuticals?

A

The latest price target for KalVista Pharmaceuticals (NASDAQ: KALV) was reported by Roth Capital on 2021-02-18. The analyst firm set a price target for 55.00 expecting KALV to rise to within 12 months (a possible 118.08% upside). 6 analyst firms have reported ratings in the last year.

Q

How much is KalVista Pharmaceuticals (KALV) stock ?

A

The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $25.22 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next KalVista Pharmaceuticals (KALV) dividend?

A

There are no upcoming dividends for KalVista Pharmaceuticals.

Q

When is KalVista Pharmaceuticals (NASDAQ:KALV) reporting earnings?

A
KalVista Pharmaceuticals’s Q4 earnings are confirmed after-market from now on June 30, 2021.
Q

When is the upcoming split for KALV?

A

There is no upcoming split for KalVista Pharmaceuticals.